Oramed Pharmaceuticals Inc. (ORMP)
PHARMACEUTICAL PREPARATIONS
- Headquarters
- United States
- Employees
- 13
- Market Cap
- $186M
About Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
SentiSense also tracks daily options readings for Oramed Pharmaceuticals Inc.: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Oramed Pharmaceuticals Inc. stock analysis, sentiment tracking, and market intelligence on SentiSense.